Uppsala University
Uppsala, 75185, Sweden
NCT Number: NCT04597866
Complex regional pain syndrome, CRPS, is an uncommon but often very disabling chronic pain syndrome characterized by, beside pain: sensory disturbances, peripheral autonomic changes and inflammatory features. The diagnosis is subdivided in CRPS type 1 where no nerve injury has been identified, and CRPS type 2 when a major nerve injury has been verified.
A combination of exposure in vivo, a form of behaviour therapy where the patient is gradually confronted with avoided movements and activities, and interventions directly targeting a hypothesized cortical reorganisation is an interesting novel approach for treating CRPS.
The present study consists of (1) a qualitative interview study with 10-15 subjects that has received this form of treatment, in order to better understand their experience and effects of the treatment, and (2) a case series with long-term follow-up of 3-5 subjects that received the treatment för 5-8 years ago, in order to study the long term effects of the treatment.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Uppsala, 75185, Sweden
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A combination of exposure in vivo and interventions directly targeting the cortical reorganization for treating CRPS.
Time frame: 1 day
Whether the subject still fulfill diagnostic criteria for CRPS
Time frame: 1 day
A qualitative interview targeting the subjects own experience of the treatment and its effect
Time frame: 1 day
Subjective level of pain on a Likert-scale 0-10 (NRS)
Time frame: 1 day
Quality of life, measured with the RAND-36 (0-100, higher scores mean a better outcome)
Time frame: 1 day
Global impression of change measured with a single question (0-6, higher scores mean a better outcome)
Time frame: 1 day (0-156, higher scores mean a better outcome)
Measured with the Chronic Pain Acceptance Questionnaire, CPAQ (0-156, higher scores mean a better outcome)
Time frame: 1 day (0-52, lower scores mean a better outcome)
Measured with the Tampa Scale of Kinesiophobia, TSK (0-52, lower scores mean a better outcome)
Time frame: 1 day (0-52, lower scores mean a better outcome)
Measured with Pain Catastrophizing Scale, PCS (0-52, lower scores mean a better outcome)
Time frame: 1 day (0-100, lower scores mean a better outcome)
Measured with the Photograph Series of Daily Activities, PHODA (0-100, lower scores mean a better outcome)
Time frame: 1 day (0-36, lower scores mean a better outcome)
Measured with a five item questionnaire (0-36, lower scores mean a better outcome)
Time frame: 1 day
EuroQol 5D, EQ-5D (0-15, higher scores means a better outcome)
Time frame: 1 day
Life Satisfaction Questionnaire, LiSat 11 (11-66, higher scores means a better outcome)
Uppsala University
Other
Treatment of Complex Regional Pain Syndrome, a Qualitative Interview Study and a Case Series With Long-term Follow-up
Acronym: TORNADO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsNCT04732325
Autonomic Nervous System Diseases, Back Pain
Ann Arbor, Michigan, United States
View Trial DetailsNCT05459324
Autonomic Nervous System Diseases, Back Pain
Albany, New York, United States
View Trial DetailsNCT06241820
Autonomic Nervous System Diseases, Chronic Pain
Seoul, South Korea
View Trial Details